Effect of Helicobacter pylori on cyclooxygenase-2 and inducible nitric oxide synthase in patients with gastric precancerous lesions and its clinical significance

Zhang,Hui; Ding,Chunsheng; Suo,Zhimin; Kang,Yuhua

doi:10.3892/etm.2015.2387

June-2015 Volume 9 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

June-2015 Volume 9 Issue 6

Full Size Image

Article

Effect of Helicobacter pylori on cyclooxygenase-2 and inducible nitric oxide synthase in patients with gastric precancerous lesions and its clinical significance

Authors:
- Hui Zhang
- Chunsheng Ding
- Zhimin Suo
- Yuhua Kang
View Affiliations / Copyright

Affiliations: Department of Digestive Medicine, Henan University Huaihe Hospital, Kaifeng, Henan 475000, P.R. China
Pages: 2364-2368
|
Published online on: March 26, 2015

https://doi.org/10.3892/etm.2015.2387
Expand metrics +

Abstract

The aim of this study was to investigate the effect of Helicobacter pylori (Hp) on cyclooxygenase‑2 (COX‑2) and inducible nitric oxide synthase (iNOS) levels in patients with gastric precancerous lesions and its clinical significance. A total of 114 patients with gastric precancerous lesions, 57 whom were positive for Hp (observation group) and 57 of whom were negative for Hp (control group), were selected for the study. The mRNA levels of COX‑2 and iNOS in the gastric precancerous lesion tissue from the two groups of patients were analyzed through the reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). The protein expression levels of COX‑2 and iNOS were analyzed using western blotting and an iNOS kit, respectively. In addition, normal human gastric mucosal GES‑1 cells were cultured in vitro and stimulated by Hp for 3, 6, 9 and 12 h. The variations in the mRNA and protein levels of COX‑2 and iNOS were then analyzed via RT‑qPCR and western blotting. Compared with the control group, the mRNA levels of COX‑2 and iNOS in the gastric tissue from the observation group were significantly increased (P<0.05). Furthermore, the expression level of COX‑2 and iNOS protein in the gastric tissue from the observation group was significantly higher than that in the tissue from the control group (P<0.05). In vitro analysis showed that the COX‑2 and iNOS mRNA and protein levels were significantly increased in the Hp‑stimulated normal human gastric mucosal GES‑1 cells compared with those in the unstimulated cells. Furthermore, the effect was time‑dependent (P<0.05). In conclusion, COX‑2 and iNOS are the main inflammatory markers. Hp can induce high expression levels of COX‑2 and iNOS in gastric precancerous lesion tissue, which may be associated with the occurrence and development of gastric precancerous lesions.

View Figures

View References

1	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
2	Falt P, Hanousek M, Kundrátová E and Urban O: Precancerous conditions and lesions of the stomach. Klin Onkol. 26:Suppl. S22–S28. 2013.[(In Czech)]. View Article : Google Scholar : PubMed/NCBI
3	Rugge M, Capelle LG, Cappellesso R, Nitti D and Kuipers EJ: Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol. 27:205–223. 2013. View Article : Google Scholar : PubMed/NCBI
4	Zorzetto V, Maddalo G, Basso D and Farinati F: Immunotherapy for gastric premalignant lesions and cancer. Immunotherapy. 4:587–599. 2012. View Article : Google Scholar : PubMed/NCBI
5	Watari J and Miwa H: Precancerous lesions of the stomach. Nihon Shokakibyo Gakkai Zasshi. 107:1759–1769. 2010.[(In Japanese)]. PubMed/NCBI
6	Rizzato C, Kato I, Plummer M, et al: Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status. Int J Cancer. 133:315–322. 2013. View Article : Google Scholar : PubMed/NCBI
7	Kato I, Canzian F, Plummer M, et al: Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci. 52:254–261. 2007. View Article : Google Scholar : PubMed/NCBI
8	Deng X, Liu ZW, Wu FS, Li LH and Liang J: A clinical study of weining granules in the treatment of gastric precancerous lesions. J Tradit Chin Med. 32:164–172. 2012. View Article : Google Scholar : PubMed/NCBI
9	Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C and Kaidi A: The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 30:377–386. 2009. View Article : Google Scholar : PubMed/NCBI
10	Chell S, Kaidi A, Williams AC and Paraskeva C: Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. Biochim Biophys Acta. 1766:104–119. 2006.PubMed/NCBI
11	Chu AJ, Chou TH and Chen BD: Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications. Front Biosci. 9:2697–2713. 2004. View Article : Google Scholar : PubMed/NCBI
12	Janakiram NB and Rao CV: iNOS-selective inhibitors for cancer prevention: promise and progress. Future Med Chem. 4:2193–2204. 2012. View Article : Google Scholar : PubMed/NCBI
13	Digestive Disease Branch of Chinese Medical Association: National seminar consensus on chronic gastritis. Zhong Hua Xiao Hua Za Zhi. 20:199–201. 2000.[(In Chinese)].
14	Correa P and Houghton J: Carcinogenesis of Helicobacter pylori. Gastroenterology. 133:659–672. 2007. View Article : Google Scholar : PubMed/NCBI
15	Kato I, van Doorn LJ, Canzian F, et al: Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int J Cancer. 119:1666–1671. 2006. View Article : Google Scholar : PubMed/NCBI
16	Zhang J, Luo J, Ni J, et al: MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells. Eur J Histochem. 58:22622014. View Article : Google Scholar : PubMed/NCBI
17	Jana D, Sarkar DK, Ganguly S, et al: Role of cyclooxygenase 2 (COX-2) in prognosis of breast cancer. Indian J Surg Oncol. 5:59–65. 2014. View Article : Google Scholar : PubMed/NCBI
18	Kim JM, Kim JS, Jung HC, Song IS and Kim CY: Up-regulation of inducible nitric oxide synthase and nitric oxide in Helicobacter pylori-infected human gastric epithelial cells: possible role of interferon-gamma in polarized nitric oxide secretion. Helicobacter. 7:116–128. 2002. View Article : Google Scholar : PubMed/NCBI
19	Li JB, Li XM and Zhan W: Expression of VEGF and iNOS protein in gastric cancer and precancerous lesions. Yi Bao Yu Fen Zi Mian Yi Za Zhi. 27:561–562. 2011.[(In Chinese)].
20	Szlachcic A, Krzysiek-Maczka G, Pajdo R, et al: The impact of asymmetric dimethylarginine (ADAMA), the endogenous nitric oxide (NO) synthase inhibitor, to the pathogenesis of gastric mucosal damage. Curr Pharm Des. 19:90–97. 2013. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Effect of Helicobacter pylori on cyclooxygenase-2 and inducible nitric oxide synthase in patients with gastric precancerous lesions and its clinical significance

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles